| Dear Voornaam,
Welcome to your weekly Cancer Research UK Research Update email.
Translating your research can be incredibly rewarding and deliver huge benefits for patients everywhere. It can also appear complex, particularly navigating the legal, financing and business development aspects required to progress your idea to market. This is where Cancer Research Horizons comes in. This week we’ve added several new entrepreneurial opportunities to our programme, offering bespoke training, one-to-one support, and access to new networks to help entrepreneurially minded researchers navigate the translation process and accelerate lifesaving discoveries towards patients.
Read on to discover more about our newest Cancer Research Horizons Entrepreneurial Programmes: Lean Launch, Cancer Tech Accelerator, and the Venture Builder Accelerator. We’re committed to improving diversity across the programmes and you don’t have to be funded by Cancer Research UK to apply.
Also this week, congratulations to all newly elected EMBO members, including Richard Gilbertson and Madeline Lancaster.
Kind regards 
Iain  Iain Foulkes
Executive Director Research & Innovation
CEO Cancer Research Horizons
Cancer Research UK |
|
|---|
|
|---|
|
|
FUNDING AND RESEARCH OPPORTUNITIES |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
 APPLICATIONS NOW OPEN FOR TECH-LED INNOVATION PROGRAMME Do you have an early-stage technology in development that is focused on the early detection, diagnosis, monitoring or treatment of cancer?
Our Cancer Tech Accelerator is back, giving you the opportunity to learn the entrepreneurial and technical skills to translate your innovations into a startup in data, MedTech or AI.
The 6 strongest teams will be awarded £70,000, alongside 6 months of tailored mentoring to develop and validate your idea and help you form an investor-ready startup.
You don't have to be funded by Cancer Research UK to apply. Applications close on 15 September. |
|
|---|
|  INTRODUCING LEAN LAUNCH Are you looking to validate your research and test assumptions about an oncology-related idea?
Our Lean Launch Programme for early-career researchers is the latest addition to Cancer Research Horizons Entrepreneurial Programmes.
Lean Launch takes the scientific method (hypothesis, test, evaluate) and applies it to business ideas in a 10-week online programme that allows you to quickly determine whether there is a market for products or services stemming from your oncology-focused research.
Interested? Applications are now open, join the programme to secure up to £4k and training to translate your research. |
|
|---|
|
|---|
|
|
 VENTURE BUILDER INCUBATOR: TURN YOUR RESEARCH INTO A DATA-DRIVEN BUSINESS Start exploring routes to market and learn about entrepreneurship with the DDE Venture Builder Incubator, in partnership with the University of Edinburgh, which is now open to applications from PhD students and early career cancer researchers from across the UK.
Apply by 22 July to get feedback on your application and the chance to resubmit, ahead of the final deadline of 9 September.
There’s also an info session on 11 August where you can discover more about the programme from programme lead, Laura Bernal. |
|
|---|
|  JOIN THE OPEN LAB INITIATIVE Are you looking for new opportunities to exchange ideas and interact more closely with other research groups?
The Open Lab Initiative is open to any research group based in the UK undertaking cancer-related research.
Join Open Lab and expand your network, find your next research collaboration and access expert matchmakers to connect you with complementary research groups. |
|
|---|
|
|---|
|
|
 NEW PARTNERSHIP TO IMPROVE PATIENT EXPERIENCE ACROSS CLINICAL TRIALS We’re working with Stitch, a digital startup, to develop an app specifically for clinical trial patients. The project will involve people affected by cancer in the design to co-create the best possible experience for patients.
Our Centre for Drug Development plans to make the Stitch platform available to patients on its studies later this year.
The feedback that Stitch collects will be available to improve future Cancer Research UK studies, making them better for patients, and more effective at investigating novel treatments.
|
|
|---|
|  A CELEBRATION OF SANJIV GAMBHIR: 18 JULY 2022 Unite online with researchers from around the world to celebrate Sam Gambhir’s legacy, impact and scientific achievements.
Sam was a leader and pioneer in the fields of molecular imaging, early detection of cancer, and precision health, his enduring legacy can be seen in the research and innovations continuing in these fields today.
The Gambhir Symposium will highlight the on-going work in the fields he helped to cultivate. |
|
|---|
|
|---|
|
|
TARGETING PROLINE SYNTHESIS IN CAFS REDUCES TUMOUR GROWTH AND METASTASIS Targeting specific metabolic pathways in the tumour stroma can reduce the production of pro-tumorigenic extracellular matrix and, in vivo, this opposes metastasis in aggressive models of triple negative breast cancer.
Emily Kay, Sara Zanivan (Cancer Research UK Beatson Institute) and colleagues characterised the function of proline synthesis enzyme PYCR1, which was previously proposed as a vulnerability for cancer cells in several tumour types, including breast cancer. |
|
|---|
|
|---|
|
|
LAST CHANCE TO REGISTER FOR THE BRAIN TUMOUR CONFERENCE AT EARLY BIRD RATE We’ve extended early bird registration for our Brain Tumour Conference until 22 July. With 200+ abstracts submitted, spaces are filling up fast so secure your spot now and save £100 when you register.
The latest speakers to join the programme include Peter Dirks (Hospital for Sick Children, Ontario), Luis Parada (Memorial Sloan Kettering Cancer Center), Karin Straathof (UCL), Hideho Okada (University of California San Francisco) and Mariella Filbin (Dana Farber Cancer Institute).
Join us on 5–7 September to tackle the big questions in brain tumour research, with expert talks and discussion on the latest discoveries and emerging concepts, from synaptogenesis and brain cancer, to tools to manipulate the nervous system and neuro-immunology. |
|
|---|
|
|---|
|
|
| | | London, UK 05 September 2022 |
|
|---|
|
|---|
| | | Cambridge, UK 20 September 2022 |
|
|---|
|
|---|
| | | London, UK 10 October 2022 |
|
|---|
|
|---|
| | | Amsterdam, Netherlands 14 October 2022 |
|
|---|
|
|---|
| | | Portland, Oregon, USA 18 October 2022 |
|
|---|
|
|---|
| | | Manchester, UK 15 November 2022 |
|
|---|
|
|---|
| | | East Sussex, UK 04 December 2022 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
